Editorial Comment to Enfortumab vedotin versus platinum rechallenge in post-platinum post-pembrolizumab advanced urothelial carcinoma: A multicenter propensity score-matched study.

Published in: International journal of urology : official journal of the Japanese Urological Association (2023)

Keyphrases